Resverlogix Corp. has announced key scientific data was presented in an oral presentation highlighting the novel features of RVX-208 at the American Heart Association Scientific Meeting. The presentation titled “Compound RVX-208 Modulates HDL-C Levels and Function in Non-human Primates and in Early Human Trials” was presented by Dr. Jacques Genest.
Navigation
Daily News
- Job Seekers With Disabilities Face Discrimination At Application Stage, UK
- Terrence Higgins Trust Scotland Urges Young Men In Argyll & Bute To Test For Chlamydia And Gonorrhoea
- Double Success For Instituto Gulbenkian De Ciencia Scientists Working On Chromosome Segregation
- The Very First All Spanish "Surgery Robot" Is Now Operating In Malaga
- Undiagnosed Celiac Disease More Common Today Than 50 Years Ago Say US Researchers
Translator
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  | ||||||||
| By N2H | |||||||||